Jump Financial, LLC Immunity Bio, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$1.53 - $6.41 $34,631 - $145,090	22,635 New	22,635 $62,000
Q2 2023 Aug 07, 2023	BUY	$1.53 - $6.41 $34,631 - $145,090	22,635 New	22,635 $62,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $73,515 - $114,413	16,900 New	16,900 $85,000
Q2 2022 Aug 09, 2022	SELL	$2.68 - $6.14 $58,692 - $134,466	-21,900 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.05 - $7.53 $55,247 - $82,378	10,940 Added 99.82%	21,900 $123,000
Q4 2021 Feb 10, 2022	SELL	$5.67 - $10.18 $672,688 - $1.21 Million	-118,640 Reduced 91.54%	10,960 $66,000
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $127,068 - $197,323	13,857 Added 11.97%	129,600 $1.26 Million
Q2 2021 Aug 13, 2021	BUY	$13.41 - $22.4 $1.22 Million - $2.05 Million	91,305 Added 373.62%	115,743 $1.65 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $313,539 - $1.03 Million	24,438 New	24,438 $580,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.